AMATEM® Softgel 20/120 is an artemisinin-based combination therapy (ACT) formulated with Artemether (20 mg) and Lumefantrine (120 mg). It is recommended by WHO for the treatment of uncomplicated malaria, offering rapid parasite clearance and long-lasting protection against relapse.
The softgel formulation ensures faster absorption, better patient compliance, and ease of swallowing compared to conventional tablets.
Key Benefits:
• Highly effective against uncomplicated malaria (P. falciparum).
• Provides rapid relief from fever, chills, and malaria symptoms.
• Softgel capsules allow faster absorption for quicker action.
• Reduces the risk of recurrence and drug resistance when taken as prescribed.
• Convenient and well-tolerated therapy for adults and children.
Precautions:
• Use only under medical supervision.
• Not recommended for individuals allergic to Artemether, Lumefantrine, or related compounds.
• Caution in patients with heart conditions, liver or kidney impairment.
• Pregnant and breastfeeding women should consult a doctor before use.
Storage:
• Store in a cool, dry place, away from direct sunlight.
• Keep medicine out of reach of children.
Possible Side Effects:
• Headache, dizziness, loss of appetite.
• Abdominal pain, nausea, vomiting, or diarrhea.
• Rare: irregular heartbeat or hypersensitivity reactions.
• Seek medical help if serious adverse effects occur.
Dosage and Administration:
• Adults & children (≥35 kg): Standard dose is 4 capsules twice daily for 3 days (total 24 capsules), but follow physician’s instructions.
• Children <35 kg: Dosage should be adjusted according to body weight and medical advice.
• Always take with food (preferably fatty meals or milk) to enhance absorption.
• Complete the full treatment course even if symptoms improve.
Prevention of Complications:
- AMATEM® Softgel helps prevent malaria-related complications such as:
• Severe anemia
• Cerebral malaria
• Organ damage
• Relapse or drug resistance
Reviews
There are no reviews yet.